Skip to Main Content

Paper Details

Termination Based on Event Accrual in Per Protocol Versus Intention to Treat in the ROCKET AF Trial.
J Am Heart Assoc
0
2021
Factor Xa, Rivaroxaban, Stroke, Vitamin K, intracranial hemorrhage, rivaroxaban, stroke, systemic embolism, warfarin
Author NameAffiliation
Kenneth W MahaffeyStanford Center for Clinical Research (SCCR) Department of Medicine Stanford University School of Medicine Stanford CA.
Daniel E SingerDivision of General Internal Medicine Massachusetts General Hospital Boston MA.
Daniel E SingerHarvard Medical School Boston MA.
Jonathan P PicciniDuke Clinical Research Institute Duke University Durham NC.
Jonathan P PicciniDivision of Cardiology Department of Medicine Duke University School of Medicine Durham NC.
Keith A A FoxDivision of Medical and Radiological Sciences University of Edinburgh Edinburgh Scotland.
Robert M CaliffDuke Clinical Research Institute Duke University Durham NC.
Robert M CaliffDivision of Cardiology Department of Medicine Duke University School of Medicine Durham NC.
Robert M CaliffDuke Clinical Research Institute Duke University Durham NC.
Robert M CaliffDivision of Cardiology Department of Medicine Duke University School of Medicine Durham NC.
Manesh R PatelDuke Clinical Research Institute Duke University Durham NC.
Manesh R PatelDivision of Cardiology Department of Medicine Duke University School of Medicine Durham NC.
  • 1 - 12

Datasets